XML 64 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangibles and Other Assets
6 Months Ended
Jun. 30, 2012
Intangibles and Other Assets

Note 8 – Intangibles and Other Assets

The following table summarizes intangibles and other assets as of June 30, 2012:

 

     June 30, 2012  

(in millions of U.S. dollars)

   Cost      Accumulated
Amortization
     Net  

Intangibles

        

Not subject to amortization

        

Rights

   $ 45.4       $ —         $ 45.4   
  

 

 

    

 

 

    

 

 

 

Subject to amortization

        

Customer relationships

   $ 366.8       $ 130.1       $ 236.7   

Trademarks

     28.7         22.4         6.3   

Information technology

     62.2         47.8         14.4   

Other

     11.4         7.1         4.3   
  

 

 

    

 

 

    

 

 

 
     469.1         207.4         261.7   
  

 

 

    

 

 

    

 

 

 
     514.5         207.4         307.1   
  

 

 

    

 

 

    

 

 

 

Other Assets

        

Financing costs

   $ 23.2       $ 9.5       $ 13.7   

Deposits

     7.2         —           7.2   

Other

     1.4         0.3         1.1   
  

 

 

    

 

 

    

 

 

 
     31.8         9.8         22.0   
  

 

 

    

 

 

    

 

 

 

Total Intangibles & Other Assets

   $ 546.3       $ 217.2       $ 329.1   
  

 

 

    

 

 

    

 

 

 

Amortization expense of intangible and other assets was $8.8 million and $17.8 million for the three and six months ended June 30, 2012, respectively, compared to $8.9 million and $17.8 million for the comparable prior year periods.

 

The estimated amortization expense for intangibles over the next five years is:

 

(in millions of U.S. dollars)

      

Remainder of 2012

   $ 16.8   

2013

     30.4   

2014

     28.5   

2015

     26.4   

2016

     23.1   

Thereafter

     136.5   
  

 

 

 
   $ 261.7   
  

 

 

 

Our only intangible asset with an indefinite life relates to the 2001 acquisition of intellectual property from Royal Crown Company, Inc. including the right to manufacture our concentrates, with all related inventions, processes, technologies, technical and manufacturing information, know-how and the use of the Royal Crown brand outside of North America and Mexico (the “Rights”). The Rights are not subject to amortization.